Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.
Mr. Kim Kelderman est le President de Bio-Techne Corp, il a rejoint l'entreprise depuis 2018.
Quelle est la performance du prix de l'action TECH ?
Le prix actuel de TECH est de $72.4, il a augmenté de 0.08% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Bio-Techne Corp ?
Bio-Techne Corp appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Bio-Techne Corp ?
La capitalisation boursière actuelle de Bio-Techne Corp est de $11.2B
Est-ce que Bio-Techne Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 16 analystes ont établi des notations d'analystes pour Bio-Techne Corp, y compris 7 achat fort, 11 achat, 6 maintien, 0 vente et 7 vente forte